Samsung Medical Center
Rectal cancer treatment cost in South Korea typically depends on the surgical approach and disease stage, with a transrectal ultrasound (TRUS) ranging from Price on request to Price on request . Primary surgeries like a rectal resection run from AUD $27,154 to AUD $49,435, while advanced robotic options also vary by complexity. Patients generally save 30–50% compared to prices in Australia and the US, particularly in Seoul hubs like Gangnam.
Typical Rectal Cancer Treatment Costs in South Korea
Bookimed Expert Insight: For complex cases, choosing a multidisciplinary centre is essential. Asan Medical Center treats over 11,000 outpatients daily and reports high surgical volumes. For those preferring digital integration, Seoul National University Bundang Hospital uses the BESTcare system to coordinate oncology data. Korea University Anam Hospital provides specific value for patients seeking robotic surgery, as they specialise in techniques that reduce visible scarring.
| Republic of Korea | Thailand | Turkey | |
| Rectal resection | from AUD $27,154 | from AUD $16,710 | from AUD $12,846 |
| NanoKnife | from AUD $24,369 | from AUD $15,318 | from AUD $13,229 |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from AUD $32,725 | from AUD $41,776 | from AUD $9,051 |
| Gastric polyps removal | from AUD $3,899 | from AUD $4,178 | from AUD $1,057 |
| Da Vinci Robotic System | from AUD $16,710 | from AUD $38,991 | from AUD $16,710 |
No hidden fees – just official clinic prices. Pay at the clinic for Rectal cancer treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Rectal cancer treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Rectal cancer treatment journey.
Dr. Yu Yeonghun is a gastrointestinal surgeon with a Ph.D. in Medicine. He specializes in hepato-pancreato-biliary (HPB) diseases and cancers. His focus includes liver, pancreas, biliary tract, and gallbladder cancers, as well as cholelithiasis and other gallbladder diseases.
He completed his internship and general surgery residency at CHA Bundang Medical Center. He then finished an HPB surgery fellowship at Samsung Medical Center. He has served as Clinical Assistant Professor of Surgery at Konkuk University Choongju Hospital and at Samsung Medical Center. He later became Professor of Surgery at Eulji University Hospital.
He is a Lifetime Member of The Korean Surgical Society and the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS). He serves on the KAHBPS Planning Committee and Tumor Registry Committee.
Dr. Park Sundo is a specialist in gastrointestinal and general surgery at Naeun Hospital. His expertise includes colorectal, proctology, breast, thyroid, laparoscopic, biliary, pancreatic, and pediatric surgery.
Key treatments include proctologic surgery, such as hemorrhoidectomy and care for hemorrhoids and anal fistula. He performs laparoscopic surgery for gallstones (cholelithiasis) and appendicitis. His oncology care covers gastric and colorectal cancer. He also performs hernia repair. Breast and thyroid care includes treatment of tumors and Mammotome biopsy. He treats varicose veins and severe burns. Pediatric surgery includes hernia repair and general pediatric procedures.
Dr. Kim Taekhyeon is a gastrointestinal surgeon and the Chief of Gastrointestinal Surgery at Naeun Hospital. He received his M.D. and M.S. from Chung-Ang University College of Medicine. He completed an internship at Sungae Hospital and a general surgery residency at Chung-Ang University Hospital. He then finished a fellowship in gastrointestinal surgery at Seoul St. Mary’s Hospital. He previously served as an attending surgeon at Gwangmyeong Sungae Hospital.
His research covers survivin and HSP90 in colorectal cancer, second primary cancers in patients with gastric cancer, and Borrmann type IV gastric carcinoma. He reported outcomes of laparoscopic totally extraperitoneal inguinal hernia repair in 92 cases. His clinical practice includes cancers and diseases of the stomach, esophagus, and small bowel. He also treats hernias, gallstones and cholecystitis, appendicitis, anal disease, varicose veins, and burns.
The Republic of Korea reports an overall colorectal cancer survival rate of approximately 74%. Leading Seoul hospitals report success rates exceeding 92% for rectal cancer specifically. These outcomes involve robotic-assisted techniques and total neoadjuvant therapy. This includes targeted chemotherapy and radiation before surgery.
Bookimed Expert Insight: While general stats are high, Korean medical infrastructure provides a safety advantage. Seoul National University Bundang Hospital uses the digital BESTcare system to reduce medical errors. This focus explains why centres like Samsung Medical Center manage over 45,000 operations annually.
Patient Consensus: Patients emphasise that early diagnosis remains the most critical factor for success in Korea. Many note that multidisciplinary care involving surgeons, oncologists, and stoma support provides comprehensive treatment.
South Korean surgeons specialise in minimally invasive techniques for rectal cancer. Robotic and laparoscopic procedures account for nearly 90% of cases. Facilities like Samsung Medical Center and Severance Hospital use the Da Vinci robotic system. This allows for precise mesorectal excision. These approaches report survival rates exceeding 92%.
Bookimed Expert Insight: Many countries treat rectal cancer generally. However, South Korean centres like Seoul National University Bundang Hospital use digital BESTcare systems. Linking surgical robotics with digital tracking reduces medical errors during complex oncology protocols. This infrastructure supports the country's high 92% five-year survival rate for rectal cancer patients.
Leading South Korean hospitals for rectal cancer include Samsung Medical Center, Severance Hospital, and Asan Medical Center. These JCI-accredited facilities specialise in robotic surgery using the Da Vinci system. They offer multidisciplinary care, combining chemotherapy, radiotherapy, and imaging for precise treatment outcomes in Seoul.
Bookimed Expert Insight: While many centres offer robotic surgery, Korea University Anam Hospital stands out for inventing specific robotic techniques. Their surgical volume of 1,300,000+ patients yearly suggests deep expertise in complex cases. Patients should look for these high-volume centres. They often have dedicated multidisciplinary tumour boards for coordinated care.
Patient Consensus: Patients recommend choosing large tertiary university hospitals in South Korea for coordinated care. Many suggest obtaining a second opinion at these major centres. This helps to confirm pathology and imaging results before starting intensive treatment.
A permanent stoma is not always required after rectal cancer surgery in South Korea. Surgeons prioritise sphincter-saving procedures for tumours in the upper or middle rectum. Clinics in Seoul use robotic systems and pre-operative therapies to avoid permanent bags. These tools also help with successful tumour removal.
Bookimed Expert Insight: Many Australian patients expect a stoma based on initial scans. However, Seoul's high-volume centres often change this plan during surgery. Clinics like Seoul National University Hospital serve over 10,000 patients daily. They report that robotic techniques allow surgeons to reach lower tumours than traditional surgery. This helps increase the chances of a temporary stoma rather than a permanent one.
Patient Consensus: Patients note that a stoma does not always mean a permanent lifestyle change. Many were surprised that findings during surgery in Korean hospitals often allowed for future reversal.
International patients can obtain a second opinion for rectal cancer in the Republic of Korea. Leading Seoul hospitals provide specialised oncology consultations. These facilities use JCI-accredited standards and digital medical records to review external pathology and imaging. Most centres offer virtual consultations within days.
Bookimed Expert Insight: While many centres are high-volume, SNUH and Severance Hospital manage massive patient loads. Severance sees 4 million patients annually. This volume means Korean specialists often see rare rectal cancer subtypes weekly. Other international doctors might only see these once a year.
Patient Consensus: Patients advise confirming if the hospital reviews external CT or MRI scans first. They suggest asking about specialist turnaround times. Most also recommend using international patient offices to coordinate interpreters for smoother communication during consultations.
Plan for a total stay of 4 to 6 weeks in the Republic of Korea. This window allows 3 to 7 days for diagnostics. Hospitalisation usually lasts 2 to 10 days. Patients should remain nearby for 14 days after discharge for flight safety.
Bookimed Expert Insight: Major Seoul centres like Samsung Medical Center and Asan Medical Center handle massive volumes. Asan performs over 65,000 operations annually. This high turnover often results in faster discharge times. However, Australian patients should not equate a quick hospital discharge with being fit to fly. Korea University Anam Hospital focuses on minimal blood loss and rapid recovery through robotic surgery. This can shorten the hospital stay. Still, the 14-day post-op local window remains vital for long-haul travel safety.
Patient Consensus: Patients note that rectal surgery often involves temporary stomas or drains. These require local monitoring. Australians should avoid tight return bookings. Bowel function recovery often takes longer than expected in Korea.